Workplace program aims to prevent pain in physical jobs
NCT ID NCT07466680
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a workplace program called GLAD can be used to prevent muscle and joint pain in blue-collar workers. 70 workers and safety professionals took part in an 8-week program with education, ergonomic changes, and exercises. The main goal was to see if workers would accept and use the program, not yet to prove it prevents pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GLAD intervention (behavioral program with education, ergonomics, and exercises)
- What this could lead to
- If successful, this could lead to a practical program that reduces pain and injury risk for workers with physically demanding jobs.
- What could go wrong
- This is a small feasibility study, not a large trial. It only measures acceptance and practicality, not whether the program actually prevents pain long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULOSKELETAL DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The National Research Centre for the Working Environment
Copenhagen, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?